Among cancer survivors, Klotho levels in Q4 showed the most significant decline compared to those in Q1, with a coefficient of β = -59.13 (95% CI: -116.43, -1.83, P = 0.0478; P for trend = 0.0233). Here, KL is linked to cancer.